drugset

drugset / Trial / NCT02072447

Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study

NCT02072447 ↗

Phase 0 Completed 8 enrolled Seoul National University Hospital

NaSingle-groupOpen-labelBasic science

Summary

This study aims to determine the absolute bioavailability of YH4808 using simultaneous oral therapeutic- and \[14C\]-labeled intravenous microdoses.

Timeline

Start: 2014-03
Primary completion: 2014-04
Completion: 2014-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	YH4808	Other / unclassified	—	Oral

Indications